Irving Dark

Irving is an International Operations and Business Development Executive with a proven track record for establishing and growing specialty Clinical Research Organizations.

 Irving Dark Irving Dark is a biometrics Subject Matter Expert with over 30 years of industry experience guiding drug, biologic, and medical device products successfully through the development process. Currently, he is on the Board of Directors of MMS, Founder/Managing Director of Sun Rock Partners, and an Affiliate Partner at Lindsay Goldberg.

Irving established the Clinical Research Services division at Cytel and served as Senior Vice President of Project Based Services for over 13 years. Prior to Cytel, he held senior leadership roles at Veristat, where he established and oversaw several core business units.

Earlier in his career, Irving held key positions at PAREXEL, where he managed Phase I – III clinical trials in the US, South America, Europe and Asia. Major therapeutic areas of projects included: lipid-lower agent (CRESTOR®), HIV (NELFINAVIR®), acromegaly (SOMATULINE®), and Stroke.

Irving has an in-depth knowledge of clinical development and biometrics, is co-author of numerous published clinical studies, and a DIA invited speaker. Irving holds Bachelor of Arts in Economics from the University of Rhode Island.